Article Text

other Versions

No impact of serum uric acid on the outcome of recent-onset arthritis
  1. Anna Luczak1,
  2. Rachel Knevel2,
  3. T W J Huizinga2,
  4. Jessica A B van Nies2,
  5. Annette van der Helm-van Mil2,
  6. Jeska Kirsten De Vries-Bouwstra1
  1. 1Department of Rheumatology, Wrocław Medical University, Wrocław, Poland
  2. 2Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  1. Correspondence to Jeska Kirsten De Vries-Bouwstra, Department of Rheumatology, Leiden University Medical Center, C-01-R, Albinusdreef 2, P.O. Box 9600, 2300 RC Leiden, The Netherlands; j.k.de_vries-bouwstra{at}

Statistics from

Patients with rheumatoid arthritis (RA) have an almost twofold increase of cardiovascular (CV) mortality and morbidity as compared with the general population and it is thought that chronic inflammation contributes to this association.1 Serum uric acid (SUA) can contribute to low-grade inflammation via increased production of C reactive protein (CRP) and influences cytokine and superoxide production by circulating neutrophils.2 3 In RA, higher levels of SUA have been associated with a higher prevalence of CV disease.4 At the joint level, monosodium urate crystals can negatively influence local bone remodelling by excessive osteoclast formation and reduced osteoblast differentiation.5, …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.